Notice of Award of a Sole Source Cooperative Agreement To Fund Uganda National Health Laboratories and Diagnostic Services (NHLDS), 15578 [2024-04399]
Download as PDF
<![CDATA[
15578
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
comments may be made available to the
Committee for their consideration and
public distribution. Written comments
should be submitted by email to
CLIAC@cdc.gov or to the contact person
above. All written comments will be
included in the meeting minutes posted
on the CLIAC website.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–04432 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Sole Source
Cooperative Agreement To Fund
Uganda National Health Laboratories
and Diagnostic Services (NHLDS)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000, for
Year 1 funding to NHLDS. The award
will strengthen laboratory systems in
Uganda by contributing to the
attainment of HIV epidemic control and
establishing sustainable and integrated
systems for quality assured disease
diagnostics, monitoring, and
surveillance. Funding amounts for years
2–5 will be set at continuation.
DATES: The period for this award will be
September 30, 2024, through September
29, 2029.
FOR FURTHER INFORMATION CONTACT:
Christina Mwangi, Center for Global
Health, Centers for Disease Control and
Prevention, US Embassy Kampala, US
Centers for Disease Control and
Prevention, 1577 Ggaba Road,
Telephone: 256772139023, Email:
mwn0@cdc.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:32 Mar 01, 2024
Jkt 262001
The sole
source award will strengthen Uganda’s
access to quality laboratory services
during the scale up of HIV prevention,
care, and treatment by supporting
implementation of the Uganda National
Health Laboratory Services (UNHLS)
Policy II (2016) and its Strategic Plan
(2020–2025).
NHLDS is in a unique position to
conduct this work, as it is the primary
stakeholder of laboratory-related policy
development, strategic planning, and
resources mobilization for the Ministry
of Health (MOH). Additionally, NHLDS
directly houses and manages the Central
Public Health Reference Laboratory
(CPHL) which is the national reference
laboratory for HIV early infant diagnosis
and viral load, national microbiology
reference laboratory, national
Tuberculosis (TB) reference laboratory,
the national laboratory biorepository
and national equipment calibration
center. Furthermore, the NHLDS is the
primary coordinator of the integrated
national laboratory specimen
transportation network that handles
both HIV, TB and outbreak specimen
referral across the country.
SUPPLEMENTARY INFORMATION:
Summary of the Award
Recipient: Uganda National Health
Laboratories and Diagnostic Services
(NHLDS).
Purpose of the Award: The purpose of
this award is to strengthen laboratory
systems in Uganda by contributing to
the attainment of HIV epidemic control
and establishing sustainable and
integrated systems for quality assured
disease diagnostics, monitoring, and
surveillance.
Amount of Award: For NHLDS, the
approximate year 1 funding amount will
be $10,000,000 in Federal Fiscal Year
(FYY) 2024 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003)
[22 U.S.C. 7601, et seq.] and Public Law
110–293 (the Tom Lantos and Henry J.
Hyde United States Global Leadership
Against HIV/AIDS, Tuberculosis, and
Malaria Reauthorization Act of 2008),
and Public Law 113–56 (PEPFAR
Stewardship and Oversight Act of 2013).
Period of Performance: The period for
this award will be September 30, 2024,
through September 29, 2029.
Dated: February 26, 2024.
Jamie Legier,
Acting Director, Office of Grants Services,
Centers for Disease Control and Prevention.
[FR Doc. 2024–04399 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Communications
and Public Engagement Workgroup
(CPEW) of the Advisory Committee to
the Director (ACD), CDC
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership to the Communications
and Public Engagement Workgroup
(CPEW) of the Advisory Committee to
the Director, CDC. The CPEW
workgroup consists of approximately 15
members who are experts in the fields
associated with communications,
including public relations, health
communication, risk communication,
communication research, and
marketing; community and partner
engagement; public health science and
practice, including implementation; and
behavioral science/behavior change
campaigns.
SUMMARY:
Nominations for membership on
the CPEW workgroup must be received
no later than March 28, 2024. Late
nominations will not be considered for
membership.
ADDRESSES: All nominations (cover
letters and curriculum vitae) should be
emailed to ACDirector@cdc.gov with the
subject line: ‘‘Nomination for CDC ACD
Communications and Public
Engagement Workgroup.’’
FOR FURTHER INFORMATION CONTACT: Kate
Galatas, MPH, Senior Communications
Specialist, Office of Communications,
Centers for Disease Control and
Prevention, 1600 Clifton Road (MS
H21–11), Atlanta, GA 30329–4027,
Telephone: (404) 639–2064; Email:
ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD,
CDC Advisory Committee to the
Director shall (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
DATES:
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Page 15578]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04399]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
Uganda National Health Laboratories and Diagnostic Services (NHLDS)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $10,000,000, for Year 1 funding to NHLDS. The
award will strengthen laboratory systems in Uganda by contributing to
the attainment of HIV epidemic control and establishing sustainable and
integrated systems for quality assured disease diagnostics, monitoring,
and surveillance. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for this award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Christina Mwangi, Center for Global
Health, Centers for Disease Control and Prevention, US Embassy Kampala,
US Centers for Disease Control and Prevention, 1577 Ggaba Road,
Telephone: 256772139023, Email: [email protected].
SUPPLEMENTARY INFORMATION: The sole source award will strengthen
Uganda's access to quality laboratory services during the scale up of
HIV prevention, care, and treatment by supporting implementation of the
Uganda National Health Laboratory Services (UNHLS) Policy II (2016) and
its Strategic Plan (2020-2025).
NHLDS is in a unique position to conduct this work, as it is the
primary stakeholder of laboratory-related policy development, strategic
planning, and resources mobilization for the Ministry of Health (MOH).
Additionally, NHLDS directly houses and manages the Central Public
Health Reference Laboratory (CPHL) which is the national reference
laboratory for HIV early infant diagnosis and viral load, national
microbiology reference laboratory, national Tuberculosis (TB) reference
laboratory, the national laboratory biorepository and national
equipment calibration center. Furthermore, the NHLDS is the primary
coordinator of the integrated national laboratory specimen
transportation network that handles both HIV, TB and outbreak specimen
referral across the country.
Summary of the Award
Recipient: Uganda National Health Laboratories and Diagnostic
Services (NHLDS).
Purpose of the Award: The purpose of this award is to strengthen
laboratory systems in Uganda by contributing to the attainment of HIV
epidemic control and establishing sustainable and integrated systems
for quality assured disease diagnostics, monitoring, and surveillance.
Amount of Award: For NHLDS, the approximate year 1 funding amount
will be $10,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
Period of Performance: The period for this award will be September
30, 2024, through September 29, 2029.
Dated: February 26, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-04399 Filed 3-1-24; 8:45 am]
BILLING CODE 4163-18-P
